Cardiology in New York

Fine Surgical Instruments, Inc. is a leading manufacturer and distributor of precision surgical instruments based in Hempstead, New York. The company supplies the global medical industry with an extensive range of high-quality surgical instruments across multiple specialties. Their comprehensive product portfolio includes diagnostic instruments, scalpels, scissors, forceps, needle holders, retractors, suturing instruments, and specialty tools for ophthalmology, ENT, gynecology, obstetrics, orthopedics, cardiology, urology, thoracic, neurosurgery, and bariatric procedures. Fine Surgical serves hospitals, surgical centers, and medical practitioners worldwide, offering both standard surgical instruments and specialized equipment for various surgical disciplines. The company provides an online catalog for procurement efficiency and maintains dedicated domestic and international sales teams.

Aktina Medical Corp. is a radiation oncology equipment and services company specializing in stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), and precision localization and immobilization solutions for LINAC (linear accelerator) treatments. The company manufactures and distributes patient immobilization systems, respiratory compression devices, cone collimators for small-field radiation delivery, and quality assurance systems for radiation therapy equipment. Primary product lines include the positionPRO modular immobilization system (offering pitch and roll correction for cranial, cervical spine, and head/neck treatments), SBRT systems, Elekta small-field circular cones, respiratory compression belts, and the isoPoint machine vision platform for LINAC isocenter optimization and calibration. Aktina also provides medical physics consultation services, diagnostic and therapeutic physics support, and quality assurance solutions including the SpiroCheck Duo system for active breathing control (ABC) validation. The company serves radiation oncology departments, cancer centers, and tertiary care hospitals requiring high-precision patient positioning and LINAC calibration for intracranial, head/neck, and body-based radiation treatments. Products are designed for compatibility with Elekta LINAC platforms and emphasize both treatment precision and patient comfort through innovative immobilization technology.

Delcath Systems, Inc. is a commercial-stage interventional oncology company specializing in minimally invasive treatments for primary and metastatic liver cancers. The company's flagship product, HEPZATO KIT™ (melphalan) for Injection/Hepatic Delivery System (HDS), received FDA approval for treating adult patients with metastatic uveal melanoma. In Europe, the equivalent product is marketed as CHEMOSAT® Hepatic Delivery System for melphalan percutaneous hepatic perfusion (PHP). The company addresses a significant clinical gap: liver cancers affect approximately 1.2 million people globally annually, yet treatment options remain limited. Delcath's interventional oncology platform delivers targeted chemotherapy directly to hepatic tumors via percutaneous hepatic perfusion, enabling concentrated drug delivery while minimizing systemic exposure. The company is positioned as a leader in safe, effective, and targeted treatments for patients with liver metastases, including secondary cancers from uveal melanoma and other primary hepatic malignancies. HEPZATO KIT represents a recent FDA-approved advancement in the interventional oncology space, expanding therapeutic options for previously underserved patient populations.

Sun Scientific is a solutions-focused medical device company specializing in patient-centric treatments for venous and lymphatic disease. The company develops innovative compression therapy systems and integrated wound care solutions designed for ease of use, comfort, and adherence. Sun Scientific's flagship products include the Aero-Wrap® adjustable compression system (available for upper and lower extremities), AeroDVx® intermittent compression system, and complementary wound care products including ExuCare®, UnnaCare™, AeroBolster™, AeroOffloader™, and HemoWrap® vascular access solutions. All products emphasize user-friendly application, adjustable pressure control via the AeroGauge™ hand pump, breathable design, and support for chronic venous insufficiency and lymphedema management. Sun Scientific facilitates insurance coverage processes and provides ongoing clinical and patient education resources to optimize treatment adherence and clinical outcomes.

Nasiff Associates, Inc. is a US-based medical technology manufacturer specializing in PC-based ECG (electrocardiogram) diagnostic systems. Founded in 1989 and veteran-owned, the company designs and manufactures CardioCard ECG systems for use in hospitals, clinical offices, telehealth platforms, and home-based medical services. All devices are manufactured domestically in the United States and feature integrated software designed to connect with major EMR systems via the proprietary Cardio Universal EMR Interface. The product line includes resting ECG machines, stress testing systems, and Holter monitoring devices, all running on a unified software platform that allows clinicians to manage multiple diagnostic ECG modalities through a single interface. Nasiff markets its solutions as providing accurate signal acquisition, reliable interpretation, and meaningful clinical decision-making support for cardiovascular disease screening and management. The company emphasizes all-American sales and technical support, with a dedicated US-based customer support team providing live technical assistance. FDA clearance is obtained for its devices, and the company holds veteran-owned small business status.

Image Monitoring USA Inc is a Buffalo, NY-based distributor and supplier of advanced transcranial Doppler (TCD) and peripheral vascular testing systems. The company specializes in non-invasive vascular diagnostic equipment serving neurologists, radiologists, cardiologists, intensivists, neonatologists, anesthesiologists, stroke specialists, and researchers. Primary product lines include the Dolphin IQ and Dolphin 4D TCD systems with robotic headset options (XF Robotic Headset) for short- and long-term cerebrovascular monitoring, and the Falcon series of physiologic vascular testing platforms (Falcon PRO, Falcon Quad PVD, and Falcon Xpress variants FX5–FX11) for ankle-brachial index (ABI) and toe-brachial index (TBI) testing in hospital, clinic, and mobile settings. The Falcon Xpress line includes models optimized for office, mobile, and laptop-based configurations. The company maintains a team of seasoned professionals across the United States to support system selection, installation, and ongoing technical service. Equipment is marketed for use in vascular laboratories, neurology departments, ICUs, NICUs, operating rooms, and outpatient clinics. Regulatory certifications and manufacturing details are not explicitly stated on the website. The company emphasizes user-friendly interfaces, customizable workflows, reliable uptime, and dedicated customer support. Operating hours are Monday–Friday, 8:00 AM–4:30 PM EST.

Schivo is a vertically integrated contract manufacturer specializing in high-quality medical device components, sub-assemblies, and final assemblies for minimally invasive surgical systems, robotic-assisted surgical platforms, cardiovascular and neurovascular devices, and orthopedic implants. The company operates globally with best-practice manufacturing facilities and applies design-for-manufacturability principles to optimize cost, productivity, and time-to-market for OEM partners. Schivo's AFP division manufactures ultra-reliable fluid control components and sub-assemblies for laboratory chromatography instruments, genomic analysis systems, and clinical diagnostic platforms. The company provides full contract manufacturing services including new product introduction (NPI) with early-stage design-to-manufacturing integration, process qualification and validation using ISO-qualified methodologies, and comprehensive regulatory support for FDA submissions. All manufacturing processes are tracked and documented through the company's manufacturing management platform. Schivo is FDA-registered and complies with FDA quality system requirements and ISO standards. The company serves global medical device OEMs across surgical, diagnostic, and life science markets, offering value-added services that extend beyond component manufacturing to include design optimization, risk mitigation, and supply chain integration.

Mick Radio-Nuclear Instruments, Inc. is a subsidiary of BEBIG Medical GmbH (since 2021) and a recognized leader in brachytherapy instrumentation with over 40 years of manufacturing experience. The company specializes in high-dose-rate (HDR) brachytherapy systems, afterloading technology, and treatment planning systems for radiation therapy, with particular expertise in prostate and gynecological brachytherapy applications. As BEBIG's North American manufacturing and operations hub, Mick provides state-of-the-art brachytherapy solutions designed for comprehensive HDR brachytherapy applications, clinical-proven X-ray therapy product series, and innovative intraoperative radiation therapy products. The company serves radiation oncology departments and cancer treatment centers globally, offering proven clinical outcomes at competitive cost. Products are positioned as the "Gold Standard" in brachytherapy instrumentation, emphasizing quality, reliability, and decades of clinical validation in radiation therapy.

NeuralPulse Ltd. is a medical device company developing an adaptive neuromodulation therapy for drug-resistant epilepsy. The company's core product is an intracranially implantable neuromodulation device that uses a three-stage approach: probing the brain with electrical pulses to assess neural state, predicting seizure likelihood based on brain response patterns, and preventing seizures through therapeutic electrical stimulation. The technology represents a paradigm shift from passive seizure detection to active predictive neuromodulation. The company completed first-in-human clinical trials at King's College Hospital, London, demonstrating in eight drug-resistant epilepsy patients that active probing significantly improves seizure prediction accuracy compared to passive monitoring techniques and that tracking brain response to electrical stimulation is safe, ethically permissible, and well-tolerated. The founding team comprises leading neuroscientists and clinicians from King's College London, including the Chief Executive Officer (research fellow in health informatics and biostatistics), Chief Medical Officer (Professor of Epilepsy), and Chief Scientific Officer (Senior Lecturer in Clinical Neurophysiology and Honorary Clinical Neurology Consultant). Academic advisors include engineering and biomedical device experts from Oxford University and University of Washington. The company has received recognition including the Best Innovation prize at the London Institute for Healthcare Engineering Showcase (February 2025) and completed the inaugural King's MedTech Accelerator programme. Partnerships include King's College London, King's Health Partners, King's College Hospital, and CorTec (neuromodulation device manufacturer). The company is positioned within the emerging field of closed-loop neuromodulation for seizure management, targeting patients with epilepsy unresponsive to pharmaceutical interventions.

Golnit Ltd is a Ukrainian manufacturer of surgical sutures established in 1987, specializing in both absorbable and non-absorbable suture products with premium sharp needles. The company manufactures surgical sutures conforming to U.S.P. (United States Pharmacopeia) and E.P. (European Pharmacopeia) standards in an ISO 7 cleanroom facility. Golnit was the first Ukrainian suture manufacturer and the first in Ukraine to produce synthetic absorbable sutures including PGA, Polyglactin 910, Poliglecaprone 25, and Polydioxanone. Product lines include cardiovascular sutures (PTFE, polyester, polypropylene, PVDF), ophthalmic sutures (polyester, silk, nylon mono, PGA), trauma sutures (stainless steel, polyester, PVDF, nylon mono, polypropylene), obstetrics and gynecology sutures (PGA, PGLA, PGLA Rapid, polydioxanone), dental sutures (including PTFE sutures for implant and periodontal surgery), and abdominal surgery sutures (silk, braided nylon, PGA). Needles are manufactured from high-grade AISI 302 stainless steel. The company offers customization services to meet specific suture-needle combinations and maintains efficient manufacturing with typical delivery within 30 days. Distribution includes direct online sales and U.S. dental clinic sales through NET32's marketplace.

ZeptoMetrix is a leading biotechnology company specializing in quality controls, assay development services, analytical reference materials, and proficiency testing for infectious disease diagnostics and analytical markets. Founded in 1999 and headquartered in Buffalo, New York, the company operates as a division of Antylia Scientific. ZeptoMetrix serves diagnostic microbiology, oncology, environmental testing, food & agriculture, cannabis & hemp, and pharmaceutical sectors. The company offers molecular controls for diagnostic testing, analytical reference materials including certified reference materials (CRMs) for environmental contaminants (PFAS, microplastics, pesticides, organotins), food safety standards, cannabis potency testing compounds, and pharmaceutical reference standards. ZeptoMetrix provides ISO 17043-accredited proficiency testing programs, viral lysates and culture fluids, seroconversion panels, monoclonal and polyclonal antibodies, ELISA kits, microbiological controls, and oncology molecular controls. With approximately 106-200 employees and ~$10M annual revenue, ZeptoMetrix serves global customers through direct sales and distributor networks, supported by comprehensive technical documentation and regulatory compliance resources.

Elliquence LLC is a medical device manufacturer specializing in advanced radiofrequency technology for minimally invasive surgical procedures. Founded on Dr. Irving Ellman's 1959 breakthrough in radiowave technology, the company brings over 50 years of expertise in neurosurgery, endoscopic spine surgery, orthopedics, and pain management. Elliquence designs and manufactures procedure-specific instrumentation including the Disc-FX System for discectomies, Endoscopic Spine Systems with HD camera endoscopes for transforaminal and interlaminar approaches, the Surgi-Max Drill for vertebral bone removal, and the Trigger-Flex Family for ablation and hemostasis. The company holds nine patents in medical equipment and surgery. All products emphasize tissue preservation, reduced patient trauma, minimized scarring, and faster recovery. Elliquence also provides comprehensive surgical training and hands-on workshops at facilities in Baldwin NY, El Segundo CA, and Boca Raton FL to educate healthcare professionals on proper device application and technique.

Firefly Neuroscience is an FDA-cleared neurodiagnostic software platform company specializing in objective brain health assessment and early detection of neurological and psychiatric conditions. The company's flagship product, Evoke™ System, combines quantitative EEG (qEEG) and event-related potentials (ERP) analysis with proprietary AI and machine learning to translate complex brain signals into clinically actionable insights. Built on a proprietary database of over 191,000 EEG and ERP sessions from individuals aged 12–85, Evoke™ enables clinicians to identify deviations in brain function, differentiate overlapping conditions (depression, anxiety, ADHD, concussion, cognitive decline, neurodegenerative disorders), and track treatment response with precision. The platform delivers age-matched normative comparisons and cloud-based reporting to support earlier diagnosis, more targeted treatment planning, and personalized care protocols. Firefly serves healthcare practitioners seeking measurable, data-driven neurological assessment and supports CNS drug developers through biomarker development and companion diagnostic collaborations.

NovaMedUSA, Inc. is a manufacturer and distributor of specialty medical products serving anesthesiology, cardiology, neonatology, and critical care markets. The company specializes in temperature monitoring solutions, including core body temperature probes, neonatal skin temperature sensors compatible with major incubator systems (GE/Ohmeda, Dräger, Atom Medical), and wireless temperature monitoring. Product lines include fiber optic laryngoscopes (PREMIER, standard, LED, and MRI-conditional variants) for intubation procedures, esophageal stethoscopes (LIFESOUND) for heart/breath sound monitoring, and conductive patient warming systems (KOALA for adults and KOALA Infant Warmer for neonates) designed to prevent perioperative hypothermia. NovaMedUSA emphasizes energy-efficient, eco-friendly technology and SCIP-INF-10 compliant products. The company operates customer support Monday–Friday, 8:30 am–8:30 pm EST, with dedicated channels for current customers, prospective buyers, and dealer partners.

Dynarex Corporation is a full-service medical supply company founded in 1967, serving healthcare facilities, distributors, and retail partners across the United States. The company operates as a one-stop supplier of medical consumables, devices, and specialty products with a stated commitment to not selling directly to end-users, positioning itself exclusively as a B2B supplier and distributor partner. Product portfolio spans multiple categories: respiratory therapy solutions under the RESP-O2 brand, including oxygen concentrators (10L and other capacities), aerosol therapy equipment, tracheostomy care supplies, and oxygen delivery consumables; advanced wound care via the Durma brand, encompassing moisture-management dressings, medicated wound dressings, and negative pressure wound therapy (NPWT) systems; bariatric medical products under BariMax for larger-frame patient populations; infection control and safety supplies under DynaSafety; laboratory and diagnostic products via LabChoice; and emergency/code blue response supplies under Code Blue Care. Additional offerings include baby care products (talc-free formulations), antifungal powders, and various consumables commonly stocked in pharmacy and retail settings. The company serves multiple market segments including acute care hospitals, long-term care facilities, home health agencies, ambulatory care centers, pharmacies, and retail medical suppliers. Dynarex emphasizes product quality, regulatory compliance, and distributor-focused customer service. The organization maintains distribution partnerships and actively recruits distributors through its partner program.

Spellman High Voltage Electronics Corporation is a leading independent manufacturer of precision DC high voltage power supplies, X-Ray generators, and Monoblock® X-Ray sources serving medical, industrial, scientific, and security sectors. Founded in 1947, the family-owned company is headquartered in Hauppauge, New York, with over 1,500 employees globally and approximately $570 million in annual revenue. Spellman specializes in custom high voltage solutions ranging from 1 kV to 500 kV, delivering tailored power converters and X-Ray imaging products for OEMs and end-users. The company operates design and support centers across North America, Asia, and Europe, providing comprehensive after-sales support, calibration services, and compliance testing. Spellman maintains ISO 9001:2015 and ISO 14001:2015 certifications and is committed to sustainability, including offering R2-certified product recycling and disposal programs for end-of-life equipment.

Polymedco is a B2B medical diagnostics company specializing in early detection and screening solutions for life-threatening diseases. The company develops and markets two primary product lines: OC-Auto® FIT, an automated fecal immunochemical test for colorectal cancer screening, and PATHFAST® Cardiac Biomarker Analyzer, a point-of-care (POC) cardiac testing platform. OC-Auto FIT is marketed as the number-one automated noninvasive CRC screening tool globally, carrying a Tier 1 US Preventive Services Task Force guideline recommendation, and has demonstrated clinical evidence of improving patient compliance (43.8% increase), reducing annual CRC incidence (25.5% reduction), and reducing cancer mortality (52.4% reduction). The PATHFAST analyzer performs lab-quality cardiac biomarker testing from a single whole blood sample, delivering results in minutes with measurements of Troponin I, NTproBNP, D-Dimer, hsCRP, CK-MB, and Myoglobin. Both systems are designed for integration into healthcare systems, reference laboratories, and point-of-care settings. Polymedco emphasizes customer-centric support, offering customizable programmatic solutions, technical implementation support, and LIS (Laboratory Information System) integration. The company partners with healthcare systems, payors, providers, and reference laboratories to improve screening accessibility and affordability. Products feature robust clinical evidence and user-friendly design for high-volume, cost-effective screening and diagnostic workflows.